153 related articles for article (PubMed ID: 7094203)
1. Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration.
Appelbaum SJ; Mayersohn M; Dorr RT; Perrier D
Cancer Chemother Pharmacol; 1982; 8(1):93-8. PubMed ID: 7094203
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of allopurinol oral and rectal dosage forms.
Chang SL; Kramer WG; Feldman S; Ballentine R; Frankel LS
Am J Hosp Pharm; 1981 Mar; 38(3):365-8. PubMed ID: 7223751
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide.
Breithaupt B; Tittel M
Eur J Clin Pharmacol; 1982; 22(1):77-84. PubMed ID: 7094977
[TBL] [Abstract][Full Text] [Related]
4. Allopurinol kinetics.
Hande K; Reed E; Chabner B
Clin Pharmacol Ther; 1978 May; 23(5):598-605. PubMed ID: 639435
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromarone.
Colin JN; Farinotti R; Fredj G; Tod M; Clavel JP; Vignon E; Dietlin F
Eur J Clin Pharmacol; 1986; 31(1):53-8. PubMed ID: 3780828
[TBL] [Abstract][Full Text] [Related]
6. [The clinical pharmacokinetics of allopurinol. 1. Allopurinol absorption sites and dose proportionality of allopurinol/oxipurinol bioavailability].
Schuster O; Haertel M; Hugemann B; Gikalov I; Schiemann O; Fenner H
Arzneimittelforschung; 1985; 35(4):760-5. PubMed ID: 4015743
[TBL] [Abstract][Full Text] [Related]
7. [Time course of oxipurinol levels in plasma following single dose and chronic administration of allopurinol in different pharmaceutical preparations (author's transl)].
Walter-Sack I; Gröbner W; Zöllner N
Arzneimittelforschung; 1979; 29(5):839-42. PubMed ID: 582985
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics or oral and intravenous allopurinol and intravenous oxypurinol in the horse.
Mills PC; Dunnett M; Smith NC
J Vet Pharmacol Ther; 1995 Dec; 18(6):451-6. PubMed ID: 8789699
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability and pharmacokinetics of intravenously and orally administered allopurinol in healthy beagles.
Bartges JW; Osborne CA; Felice LJ; Koehler LA; Ulrich LK; Bird KA; Chen M; Sawchuk RJ
Am J Vet Res; 1997 May; 58(5):504-10. PubMed ID: 9140559
[TBL] [Abstract][Full Text] [Related]
11. [Clinical pharmacokinetics of allopurinol. 3. Allopurinol/oxipurinol pharmacokinetics following administration of a controlled release allopurinol preparation].
Gikalov I; Radivojevich F; Schiemann O; Fenner H
Arzneimittelforschung; 1986 Jun; 36(6):988-93. PubMed ID: 3741536
[TBL] [Abstract][Full Text] [Related]
12. Allopurinol: a comparative study of the bioavailability and effect on plasma uric acid of two products in tablet form.
Nissen P; Pedersen L
Biopharm Drug Dispos; 1985; 6(4):441-6. PubMed ID: 4084669
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a thiazide-allopurinol drug interaction.
Hande KR
Am J Med Sci; 1986 Oct; 292(4):213-6. PubMed ID: 3752167
[TBL] [Abstract][Full Text] [Related]
14. The bioavailability of two commercial preparations of allopurinol tablets.
Marcus M; Tse FL; Kleinberg SI
Int J Clin Pharmacol Ther Toxicol; 1982 Jul; 20(7):302-5. PubMed ID: 7107081
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.
Day RO; Graham GG; Hicks M; McLachlan AJ; Stocker SL; Williams KM
Clin Pharmacokinet; 2007; 46(8):623-44. PubMed ID: 17655371
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects.
Turnheim K; Krivanek P; Oberbauer R
Br J Clin Pharmacol; 1999 Oct; 48(4):501-9. PubMed ID: 10583019
[TBL] [Abstract][Full Text] [Related]
17. Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. II. Kinetics of allopurinol, oxipurinol, and hydrochlorothiazide.
de Vries JX; Voss A; Ittensohn A; Walter-Sack I; Löffler W; Landthaler R; Zöllner N
Clin Investig; 1994 Dec; 72(12):1076-81. PubMed ID: 7711419
[TBL] [Abstract][Full Text] [Related]
18. [The clinical pharmacokinetics of allopurinol. 2. Allopurinol/oxypurinol pharmacokinetics following allopurinol in single doses and multiple application].
Fenner H; Schiemann O; Gikalov I
Arzneimittelforschung; 1985; 35(7):1093-6. PubMed ID: 4052144
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of three formulations of ondansetron hydrochloride in healthy volunteers: 24-mg oral tablet, rectal suppository, and i.v. infusion.
VanDenBerg CM; Kazmi Y; Stewart J; Weidler DJ; Tenjarla SN; Ward ES; Jann MW
Am J Health Syst Pharm; 2000 Jun; 57(11):1046-50. PubMed ID: 10876746
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration.
Breimer DD; de Boer AG
Arzneimittelforschung; 1976; 26(3):448-54. PubMed ID: 989344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]